Tulosta

Dyslipidemiat valtimoahtaumasairauden riskitekijänä

Lisätietoa aiheesta
18.12.2017
Timo Strandberg

Kirjallisuutta

  1. Ference BA, Ginsberg HN, Graham I ym. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017;38:2459-2472 «PMID: 28444290»PubMed
  2. Mabuchi H, Koizumi J, Shimizu M ym. Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989;79:225-32 «PMID: 2914343»PubMed
  3. Cohen JC, Boerwinkle E, Mosley TH Jr ym. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-72 «PMID: 16554528»PubMed
  4. Berenson GS, Srinivasan SR, Bao W ym. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6 «PMID: 9614255»PubMed
  5. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8 «PMID: 3773199»PubMed
  6. Strandberg TE, Strandberg A, Rantanen K ym. Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up. J Am Coll Cardiol 2004;44:1002-8 «PMID: 15337210»PubMed
  7. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA 2014;312:1136-44 «PMID: 25226479»PubMed
  8. Collins R, Reith C, Emberson J ym. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-2561 «PMID: 27616593»PubMed
  9. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9 «PMID: 8836866»PubMed
  10. Faergeman O. Hypertriglyceridemia and the fibrate trials. Curr Opin Lipidol 2000;11:609-14 «PMID: 11086334»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
KÄYPÄ HOITO -SUOSITUS Dyslipidemiat
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko